Literature DB >> 27440837

Specific Blood Pressure Targets for Patients With Diabetic Nephropathy?

Guido Grassi1, Giuseppe Mancia2, Peter M Nilsson3.   

Abstract

Diabetic nephropathy represents a condition frequently detected in current clinical practice characterized by a very high cardiovascular risk profile. Blood pressure reduction via antihypertension drug treatment represents a therapeutic approach capable of exerting favorable effects on renal and cardiovascular outcomes. The purpose of this article is to review the current literature and results of key clinical trials pertaining to blood pressure goals of antihypertension treatment in these patients. The pros and cons of a less or a more intensive blood pressure goal in diabetic nephropathy will be discussed, with particular emphasis on the cardiovascular and renal effects of each therapeutic strategy.
© 2016 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27440837     DOI: 10.2337/dcS15-3020

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  7 in total

1.  Add-On Antihypertensive Medications to Angiotensin-Aldosterone System Blockers in Diabetes: A Comparative Effectiveness Study.

Authors:  Emily B Schroeder; Michel Chonchol; Susan M Shetterly; J David Powers; John L Adams; Julie A Schmittdiel; Gregory A Nichols; Patrick J O'Connor; John F Steiner
Journal:  Clin J Am Soc Nephrol       Date:  2018-03-23       Impact factor: 8.237

Review 2.  Novel insights into the pathophysiology and clinical aspects of diabetic nephropathy.

Authors:  Zubair Ilyas; Joumana T Chaiban; Armand Krikorian
Journal:  Rev Endocr Metab Disord       Date:  2017-03       Impact factor: 6.514

3.  A bidirectional Mendelian randomization study supports causal effects of kidney function on blood pressure.

Authors:  Zhi Yu; Josef Coresh; Guanghao Qi; Morgan Grams; Eric Boerwinkle; Harold Snieder; Alexander Teumer; Cristian Pattaro; Anna Köttgen; Nilanjan Chatterjee; Adrienne Tin
Journal:  Kidney Int       Date:  2020-05-23       Impact factor: 10.612

4.  Poor Control of Plasma Triglycerides Is Associated with Early Decline of Estimated Glomerular Filtration Rates in New-Onset Type 2 Diabetes in China: Results from a 3-Year Follow-Up Study.

Authors:  Chuan Wang; Lingshu Wang; Kai Liang; Fei Yan; Xinguo Hou; Fuqiang Liu; Li Chen
Journal:  J Diabetes Res       Date:  2020-09-28       Impact factor: 4.011

5.  Cellular origin and microRNA profiles of circulating extracellular vesicles in different stages of diabetic nephropathy.

Authors:  Melissa Uil; Chi M Hau; Mohamed Ahdi; James D Mills; Jesper Kers; Moin A Saleem; Sandrine Florquin; Victor E A Gerdes; Rienk Nieuwland; Joris J T H Roelofs
Journal:  Clin Kidney J       Date:  2019-10-23

6.  Renal outcomes of diabetic patients treated with combination therapy of ACE inhibitors plus either thiazide diuretics or calcium channel blockers: comparative retrospective cohort study in Northwestern Ethiopia.

Authors:  Adeladlew Kassie Netere; Esmael Ali Muhammad; Mezgebu Silamsaw Asres; Masho Tigabie Teklie
Journal:  BMJ Open       Date:  2021-11-25       Impact factor: 3.006

7.  Risk factors for nephropathy in persons with type 1 diabetes: a population-based study.

Authors:  Shilan Seyed Ahmadi; Aldina Pivodic; Ann-Marie Svensson; Hans Wedel; Björn Rathsman; Thomas Nyström; Johnny Ludvigsson; Marcus Lind
Journal:  Acta Diabetol       Date:  2022-02-24       Impact factor: 4.087

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.